BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2008586)

  • 21. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy].
    Tfelt-Hansen J; Brixen KT; Mosekilde L; Schwarz P
    Ugeskr Laeger; 2005 Feb; 167(8):924-6. PubMed ID: 15789851
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy.
    McKee RL; Caulfield MP
    Pept Res; 1989; 2(2):161-6. PubMed ID: 2520752
    [No Abstract]   [Full Text] [Related]  

  • 24. Humoral hypercalcemia of malignancy: role of parathyroid hormone-related protein.
    Blind E
    Recent Results Cancer Res; 1994; 137():20-43. PubMed ID: 7878294
    [No Abstract]   [Full Text] [Related]  

  • 25. [Severe humoral hypercalcemia, elevated level of parathyroid hormone-related protein (PTH-rp) and cutaneous squamous cell carcinoma].
    Ghislain PD; Vandecandelaere M; Espagne P; Moreau L; Gosset P; Modiano P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):429-30. PubMed ID: 12055545
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral hypercalcemia of malignancy.
    Martin TJ
    Bone Miner; 1988 Apr; 4(1):83-9. PubMed ID: 3056542
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral hypercalcemia of malignancy: some enigmas on the clinical features.
    Ikeda K; Ogata E
    J Cell Biochem; 1995 Mar; 57(3):384-91. PubMed ID: 7768974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-related peptide and hypercalcemia of malignancy.
    Goltzman D; Henderson JE
    Cancer Treat Res; 1997; 89():193-215. PubMed ID: 9204194
    [No Abstract]   [Full Text] [Related]  

  • 30. Properties of parathyroid hormone-related protein and its role in malignant hypercalcaemia.
    Martin TJ
    Q J Med; 1990 Aug; 76(280):771-86. PubMed ID: 2217682
    [No Abstract]   [Full Text] [Related]  

  • 31. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
    Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
    J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignancy-associated hypercalcemia].
    Sato K
    Nihon Naika Gakkai Zasshi; 1995 May; 84(5):808-12. PubMed ID: 7616098
    [No Abstract]   [Full Text] [Related]  

  • 33. Parathyroid hormone-related protein and hypercalcaemia of malignancy.
    Ratcliffe WA
    J Pathol; 1994 Jun; 173(2):79-80. PubMed ID: 8089809
    [No Abstract]   [Full Text] [Related]  

  • 34. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
    Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
    Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemistry and pathology of PTH-related gene products.
    Martin TJ; Moseley JM
    J Endocrinol Invest; 1992; 15(9 Suppl 6):171-7. PubMed ID: 1300336
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    West J Med; 1990 Dec; 153(6):635-40. PubMed ID: 2293469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physiopathology and therapy of hypercalcemia associated with malignancies].
    Ikeda K
    Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1212-7. PubMed ID: 10465966
    [No Abstract]   [Full Text] [Related]  

  • 39. [Expression of parathyroid hormone-related protein and pathogenesis of hypercalcemia in adult T-cell leukemia].
    Matsumoto T
    Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1255-9. PubMed ID: 2292316
    [No Abstract]   [Full Text] [Related]  

  • 40. Peptide mediators of hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    Annu Rev Med; 1990; 41():35-44. PubMed ID: 2184736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.